What is the appropriate treatment for diabetic ketoacidosis (DKA) in adults?

DKA Treatment in Adults

Begin immediate aggressive fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 ml/kg/h (1-1.5 liters) in the first hour, followed by continuous intravenous regular insulin infusion at 0.1 units/kg/h, with careful potassium replacement once renal function is confirmed. 1, 2

Initial Assessment and Diagnosis

Confirm DKA diagnosis with the triad:

• Blood glucose ≥250 mg/dL (though euglycemic DKA can occur, especially with SGLT2 inhibitors)
• Arterial pH <7.3
• Serum bicarbonate <15 mEq/L
• Positive serum or urine ketones
• Anion gap >10 mEq/L 2, 3

Obtain immediately: arterial blood gases, complete blood count with differential, comprehensive metabolic panel, serum ketones (β-hydroxybutyrate preferred over nitroprusside method), urinalysis, ECG, and cultures if infection suspected 1, 2

Fluid Resuscitation (First Priority)

This is the most critical initial intervention - DKA patients typically have 6-liter total body water deficits 1

First hour:

• 0.9% NaCl at 15-20 ml/kg/h (1-1.5 liters in average adult) 1, 2
• Do NOT delay for cardiac assessment unless overt heart failure

Subsequent fluid choice (after first hour):

• If corrected serum sodium is normal or elevated: 0.45% NaCl at 4-14 ml/kg/h
• If corrected serum sodium is low: continue 0.9% NaCl at 4-14 ml/kg/h 1
• Correct sodium for hyperglycemia: add 1.6 mEq to measured sodium for each 100 mg/dL glucose above 100 mg/dL 1

Critical safety parameter: Change in serum osmolality should not exceed 3 mOsm/kg/h to prevent cerebral edema 1, 2

Insulin Therapy

Standard approach for moderate-to-severe DKA:

• Continuous IV regular insulin infusion at 0.1 units/kg/h 2
• Do NOT start insulin until potassium is ≥3.3 mEq/L (risk of fatal arrhythmias) 1
• Target glucose decline of 50-75 mg/dL per hour 2
• If glucose doesn't fall by 50 mg/dL in first hour, double insulin infusion rate hourly until target decline achieved 2

When glucose reaches 200-250 mg/dL:

• Add 5% dextrose to IV fluids 2
• Consider reducing insulin to 0.05 units/kg/h to prevent hypoglycemia while continuing to clear ketones 4
• Continue insulin infusion until acidosis resolves - ketone clearance takes longer than glucose normalization 2

Mild DKA alternative:

• Subcutaneous or intramuscular regular insulin acceptable
• Priming dose: 0.4-0.6 units/kg (half IV bolus, half SC/IM)
• Then 0.1 unit/kg SC or IM every hour 2

Potassium Replacement (Critical)

DKA causes total body potassium depletion of 3-5 mEq/kg despite normal or elevated initial serum levels 1

Protocol:

• If K+ <3.3 mEq/L: Hold insulin, give potassium aggressively until >3.3 mEq/L
• If K+ 3.3-5.2 mEq/L: Add 20-30 mEq/L to IV fluids (2/3 KCl, 1/3 KPO4)
• If K+ >5.2 mEq/L: Hold potassium, check every 2 hours 1, 2

Monitor potassium every 2-4 hours - hypokalaemia occurs in ~50% during treatment and severe hypokalaemia (<2.5 mEq/L) increases mortality 5

Bicarbonate Therapy

Generally NOT recommended - studies show no benefit in resolution time or outcomes 6

Only consider if pH <6.9:

• 50 mmol sodium bicarbonate in 200 ml sterile water
• Infuse at 200 ml/h
• Not necessary if pH >7.0 2, 7, 2

Phosphate Replacement

Routine replacement not beneficial for clinical outcomes 2

Consider replacement only if:

• Serum phosphate <1.0 mg/dL AND
• Patient has cardiac dysfunction, anemia, or respiratory depression 2

Monitoring Requirements

Every 1-2 hours initially:

• Point-of-care glucose
• Serum electrolytes (especially potassium)

Every 2-4 hours:

• Venous pH (adequate for monitoring; arterial blood gases rarely needed after initial assessment)
• Anion gap
• Blood urea nitrogen, creatinine, osmolality 2

Use β-hydroxybutyrate for ketone monitoring - nitroprusside method is misleading as it doesn't measure the predominant ketone and may falsely suggest worsening during treatment 2, 7

Resolution Criteria

DKA is resolved when ALL of the following are met:

• Glucose <200 mg/dL
• Serum bicarbonate ≥18 mEq/L
• Venous pH >7.3
• Anion gap closed 2

Transition to Subcutaneous Insulin

Critical timing to prevent rebound hyperglycemia and recurrent ketoacidosis:

1. Administer basal insulin (long-acting analog or NPH) 2-4 hours BEFORE stopping IV insulin 6
2. Continue IV insulin for 1-2 hours after first subcutaneous dose to ensure adequate overlap 2
3. Transition to basal-bolus regimen (not sliding scale alone) 8, 6

Abrupt discontinuation of IV insulin without adequate subcutaneous coverage leads to poor glycemic control and potential DKA recurrence 2

Special Considerations

Euglycemic DKA (increasingly common with SGLT2 inhibitors):

• Diagnosis based on acidosis and ketones despite glucose <250 mg/dL
• Same treatment principles apply
• SGLT2 inhibitors should be discontinued 3-4 days before elective surgery 6, 3, 4

Precipitating factors requiring treatment:

• Infection (most common) - obtain cultures, start antibiotics
• Medication non-compliance
• New-onset diabetes
• Myocardial infarction, stroke
• Pancreatitis 1, 2

Common Pitfalls to Avoid

1. Starting insulin before adequate fluid resuscitation - worsens hypotension
2. Starting insulin with K+ <3.3 mEq/L - life-threatening arrhythmias
3. Stopping IV insulin when glucose normalizes - ketoacidosis persists
4. Abrupt transition to subcutaneous insulin - rebound hyperglycemia
5. Using nitroprusside for ketone monitoring - misleading results
6. Correcting osmolality too rapidly - cerebral edema risk
7. Routine bicarbonate use - no proven benefit, potential harm 2, 4